The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

The drug zanidatamab-hrii, sold under the brand name Ziihera, is approved for use in previously treated adults with ...

Sarrah Strimel Bentley is an optimist – even when it comes to her journey with early breast cancer. The new mother and philanthropist discusses why she’s empowered to live a happy and healthy life.

These mechanisms result in tumour growth inhibition and cell death in vitro and in vivo. In the United States, Ziihera is indicated for the treatment of adults with previously treated, unresectable or ...

NewsVoir Mumbai Maharashtra [India]2 Lung cancer remains one of the most prevalent and deadly cancers globally with approximately 22 million new cases diagnosed annually contributing to 18 of all canc ...

To improve patient outcome for breast cancer, regular monitoring and early intervention is necessary. Breast cancer monitoring involves various methods for early detection, accurate diagnosis, and ...

ImmunityBio has partnered with nCartes to automate and expedite the data fulfilment process for clinical trials.

AstraZeneca faces challenges in securing full FDA approval for Andexxa, its anticoagulant reversal therapy, due to safety ...

Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an ...

Metropolis molecular genomics study shows genetic profiling are improving survival rates: Our Bureau, Bengaluru Friday, November 22, 2024, 14:45 Hrs [IST] Metropolis Healthcare co ...